Geode Capital Management’s Akoya BioSciences AKYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-245,665
| Closed | -$319K | – | 4476 |
|
|
2025
Q2 | $319K | Sell |
245,665
-321,317
| -57% | -$387K | ﹤0.01% | 3712 |
|
|
2025
Q1 | $788K | Buy |
566,982
+1,493
| +0.3% | +$3.27K | ﹤0.01% | 3387 |
|
|
2024
Q4 | $1.3M | Buy |
565,489
+3,880
| +0.7% | +$10.3K | ﹤0.01% | 3269 |
|
|
2024
Q3 | $1.53M | Sell |
561,609
-514
| -0.1% | -$1.25K | ﹤0.01% | 3208 |
|
|
2024
Q2 | $1.32M | Buy |
562,123
+48,074
| +9% | +$153K | ﹤0.01% | 3212 |
|
|
2024
Q1 | $2.41M | Buy |
514,049
+15,874
| +3% | +$82.4K | ﹤0.01% | 3045 |
|
|
2023
Q4 | $2.43M | Buy |
498,175
+32,094
| +7% | +$133K | ﹤0.01% | 3031 |
|
|
2023
Q3 | $2.17M | Buy |
466,081
+99,465
| +27% | +$572K | ﹤0.01% | 3052 |
|
|
2023
Q2 | $2.71M | Buy |
366,616
+44,577
| +14% | +$298K | ﹤0.01% | 3014 |
|
|
2023
Q1 | $2.63M | Buy |
322,039
+14,904
| +5% | +$156K | ﹤0.01% | 2917 |
|
|
2022
Q4 | $2.94M | Buy |
307,135
+6,235
| +2% | +$76.7K | ﹤0.01% | 2907 |
|
|
2022
Q3 | $3.54M | Buy |
300,900
+111,119
| +59% | +$1.46M | ﹤0.01% | 2864 |
|
|
2022
Q2 | $2.44M | Buy |
189,781
+580
| +0.3% | +$6.01K | ﹤0.01% | 3046 |
|
|
2022
Q1 | $2.08M | Buy |
189,201
+5,986
| +3% | +$69.4K | ﹤0.01% | 3239 |
|
|
2021
Q4 | $2.81M | Buy |
183,215
+49,443
| +37% | +$647K | ﹤0.01% | 3200 |
|
|
2021
Q3 | $1.87M | Buy |
133,772
+8,074
| +6% | +$135K | ﹤0.01% | 3378 |
|
|
2021
Q2 | $2.43M | Buy |
+125,698
| New | +$2.6M | ﹤0.01% | 3203 |
|
Geode Capital Management's AKYA Position: Q3 2025 in Review
Geode Capital Management sold out of Akoya BioSciences (AKYA) in Q3 2025, closing a stake of 245,665 shares — an estimated $319K sold.
Geode Capital Management first reported a position in AKYA in Q2 2021 and held it in 17 quarters. The position peaked at $3.54M in Q3 2022. 0 funds tracked by Wall St. Rank hold AKYA as of Q3 2025.
- Geode Capital Management reported no remaining Akoya BioSciences position as of Q3 2025 after selling out during the quarter.
- Geode Capital Management sold 245,665 Akoya BioSciences shares in Q3 2025, an estimated $319K.
- Geode Capital Management first reported a position in Akoya BioSciences in Q2 2021 and held it in 17 quarters.
- Geode Capital Management's Akoya BioSciences position peaked at $3.54M in Q3 2022.
- 0 funds tracked by Wall St. Rank held Akoya BioSciences as of Q3 2025.
Based on Geode Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.